Clinical Trials Logo

Filter by:
NCT ID: NCT05019014 Completed - Alzheimer Disease Clinical Trials

Olfactory Deficits in Neurologic Disease

Start date: August 10, 2011
Phase:
Study type: Observational

The goal of this study is to examine olfactory function in preclinical subjects or individuals with neurological diseases such as Probable Alzheimer's Disease (PRAD), Frontotemporal Dementias (FTD), Dementia with Lewy Bodies (DLB), Traumatic Brain Injury (TBI), and Amyotrophic Lateral Sclerosis (ALS).

NCT ID: NCT05018910 Completed - Preterm Infant Clinical Trials

Skin to Skin and Heart Rate Variability

Start date: July 4, 2021
Phase:
Study type: Observational

The objective of this study is to monitor heart rate variability in preterm infants receiving respiratory support, including conventional mechanical ventilation, during skin-to-skin care. We hypothesize that skin to skin care will be associated with a more mature pattern of parasympathetic activity as measured by various domains of heart rate variability. Specifically, the standard deviation of the normal-to-normal interval (SDNN), the root mean squared of successive differences of normal-to-normal intervals (RMSDD), and the standard deviation of deceleration (SDDec) will decrease in infants that are receiving skin-to-skin care across all types of respiratory support compared to infants who are lying in their isolette.

NCT ID: NCT05018806 Completed - Atopic Dermatitis Clinical Trials

Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

Start date: September 9, 2021
Phase: Phase 2
Study type: Interventional

This was a parallel treatment, Phase 2, double-blind, 2-arm, placebo-controlled study with 2 staggered cohorts (2 arms in each cohort) to evaluate the efficacy and safety of rilzabrutinib in adult participants (aged at least 18 years) with moderate-to-severe AD and intolerance or inadequate response to topical corticosteroids (TCS). The total study duration per participant was expected to be approximately 21 weeks, including up to 4 weeks of screening, 16 weeks of on-treatment double-blind period, 1 week of post-treatment follow-up.

NCT ID: NCT05018689 Completed - Clinical trials for Mental Health Wellness 1

Aevidum Curriculum/Club Evaluation

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The study purpose is to evaluate the effectiveness of the Aevidum curriculum (plus/minus club) to improve adolescent mental health knowledge, help-seeking intentions, and school culture. Investigators will partner with 12 high schools for this study. Prior to the start of the 2021-2022 academic year, schools will be recruited and randomly assigned to implement the Aevidum curriculum (n=6) or the curriculum and club (n=6).

NCT ID: NCT05018234 Completed - Clinical trials for Obstructive Sleep Apnea

Safety Monitoring for a Novel 3D Printed Mandibular Advancement Device

Start date: August 4, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety profile of the novel oral appliance (OA )device and to assess patient comfort of the novel OA device.

NCT ID: NCT05018169 Completed - Depression Clinical Trials

Behavioral Activation for Treatment of Depression in Adolescents With Autism

BA-A
Start date: August 1, 2021
Phase: N/A
Study type: Interventional

In this study, the investigators will examine the feasibility, acceptability, and preliminary efficacy of a novel, behavior-based approach for treatment of depression symptoms in adolescents with autism spectrum disorder or ASD (i.e., Behavioral Activation for Adolescents with ASD, BA-A).

NCT ID: NCT05018156 Completed - Colorectal Cancer Clinical Trials

Default Genetics Referrals for Young-Onset Colorectal Cancer

Start date: November 10, 2021
Phase: N/A
Study type: Interventional

The investigators will perform a pilot implementation study of a default genetics referral process among patients with young-onset CRC diagnosed between ages 40 and 49.

NCT ID: NCT05017974 Completed - Sleep Clinical Trials

Research on Improving Sleep During Pregnancy

RISE
Start date: September 8, 2021
Phase: N/A
Study type: Interventional

The overarching goal is to utilize a randomized control design to examine acceptability, feasibility, and adherence of mindfulness-based stress reduction plus prenatal sleep supplement (MBSR+PS) compared to treatment as usual among pregnant people with poor sleep quality (n=50).

NCT ID: NCT05017818 Completed - Clinical trials for Thymidine Kinase 2 Deficiency

A Retrospective Study of Subjects With Thymidine Kinase 2 Deficiency

Start date: July 23, 2021
Phase:
Study type: Observational

This is a multicenter, multinational, retrospective chart-review study to evaluate survival in patients with Thymidine Kinase 2 deficiency (TK2d).

NCT ID: NCT05017428 Completed - Clinical trials for Postprandial Inflammation

Absorption and Digestion Kinetics of Human Metabolites

Start date: April 8, 2021
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to evaluate the effects oral supplementation with four human metabolites (spermidine, nicotinamide, palmitoylethanolamide (PEA), and oleoylethanolamide(OEA)) at varying doses on the circulating blood levels of these metabolites as well as their immediate effects on plasma functionality and postprandial inflammation. 5 young healthy subjects will participate in a four armed study consisting of a Placebo arm and a Low, Medium, and High Dose arm. Subjects will be given a standardized breakfast along with supplementation with either an escalating dose (Low: 1x, Medium: 2x, High: 3x) of a combination of spermidine, nicotinamide, PEA and OEA or a placebo control and a time course of their blood plasma will be collected after supplementation. Plasma samples will be assessed for their concentration of spermidine, nicotinamide, PEA, and OEA as well as their experimental and clinical functionalities including their anti-inflammatory, antioxidant, and cholesterol efflux abilities on primary human macrophage.